This report contains market size and forecasts of Age Related Macular Degeneration (AMD) in Global, including the following market information:
Global Age Related Macular Degeneration (AMD) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Age Related Macular Degeneration (AMD) market was valued at 1348.9 million in 2020 and is projected to reach US$ 1608.8 million by 2027, at a CAGR of 4.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Age Related Macular Degeneration (AMD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Age Related Macular Degeneration (AMD) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Age Related Macular Degeneration (AMD) Market Segment Percentages, By Type, 2020 (%)
Wet AMD
Dry AMD
China Age Related Macular Degeneration (AMD) Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Age Related Macular Degeneration (AMD) Market Segment Percentages, By Application, 2020 (%)
Men
Woman
Global Age Related Macular Degeneration (AMD) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Age Related Macular Degeneration (AMD) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Age Related Macular Degeneration (AMD) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Age Related Macular Degeneration (AMD) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Age Related Macular Degeneration (AMD) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Age Related Macular Degeneration (AMD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Age Related Macular Degeneration (AMD) Overall Market Size
2.1 Global Age Related Macular Degeneration (AMD) Market Size: 2021 VS 2027
2.2 Global Age Related Macular Degeneration (AMD) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Age Related Macular Degeneration (AMD) Players in Global Market
3.2 Top Global Age Related Macular Degeneration (AMD) Companies Ranked by Revenue
3.3 Global Age Related Macular Degeneration (AMD) Revenue by Companies
3.4 Top 3 and Top 5 Age Related Macular Degeneration (AMD) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Age Related Macular Degeneration (AMD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) Players in Global Market
3.6.1 List of Global Tier 1 Age Related Macular Degeneration (AMD) Companies
3.6.2 List of Global Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Age Related Macular Degeneration (AMD) Market Size Markets, 2021 & 2027
4.1.2 Wet AMD
4.1.3 Dry AMD
4.2 By Type - Global Age Related Macular Degeneration (AMD) Revenue & Forecasts
4.2.1 By Type - Global Age Related Macular Degeneration (AMD) Revenue, 2016-2021
4.2.2 By Type - Global Age Related Macular Degeneration (AMD) Revenue, 2022-2027
4.2.3 By Type - Global Age Related Macular Degeneration (AMD) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Age Related Macular Degeneration (AMD) Market Size, 2021 & 2027
5.1.2 Men
5.1.3 Woman
5.2 By Application - Global Age Related Macular Degeneration (AMD) Revenue & Forecasts
5.2.1 By Application - Global Age Related Macular Degeneration (AMD) Revenue, 2016-2021
5.2.2 By Application - Global Age Related Macular Degeneration (AMD) Revenue, 2022-2027
5.2.3 By Application - Global Age Related Macular Degeneration (AMD) Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Age Related Macular Degeneration (AMD) Market Size, 2021 & 2027
6.2 By Region - Global Age Related Macular Degeneration (AMD) Revenue & Forecasts
6.2.1 By Region - Global Age Related Macular Degeneration (AMD) Revenue, 2016-2021
6.2.2 By Region - Global Age Related Macular Degeneration (AMD) Revenue, 2022-2027
6.2.3 By Region - Global Age Related Macular Degeneration (AMD) Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Age Related Macular Degeneration (AMD) Revenue, 2016-2027
6.3.2 US Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.3.3 Canada Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.3.4 Mexico Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Age Related Macular Degeneration (AMD) Revenue, 2016-2027
6.4.2 Germany Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.4.3 France Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.4.4 U.K. Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.4.5 Italy Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.4.6 Russia Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.4.7 Nordic Countries Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.4.8 Benelux Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Age Related Macular Degeneration (AMD) Revenue, 2016-2027
6.5.2 China Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.5.3 Japan Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.5.4 South Korea Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.5.5 Southeast Asia Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.5.6 India Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Age Related Macular Degeneration (AMD) Revenue, 2016-2027
6.6.2 Brazil Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.6.3 Argentina Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Age Related Macular Degeneration (AMD) Revenue, 2016-2027
6.7.2 Turkey Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.7.3 Israel Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.7.4 Saudi Arabia Age Related Macular Degeneration (AMD) Market Size, 2016-2027
6.7.5 UAE Age Related Macular Degeneration (AMD) Market Size, 2016-2027
7 Players Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Age Related Macular Degeneration (AMD) Major Product Offerings
7.1.4 Bayer Age Related Macular Degeneration (AMD) Revenue in Global (2016-2021)
7.1.5 Bayer Key News
7.2 F. HoffmannLa Roche
7.2.1 F. HoffmannLa Roche Corporate Summary
7.2.2 F. HoffmannLa Roche Business Overview
7.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Major Product Offerings
7.2.4 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Revenue in Global (2016-2021)
7.2.5 F. HoffmannLa Roche Key News
7.3 Regeneron
7.3.1 Regeneron Corporate Summary
7.3.2 Regeneron Business Overview
7.3.3 Regeneron Age Related Macular Degeneration (AMD) Major Product Offerings
7.3.4 Regeneron Age Related Macular Degeneration (AMD) Revenue in Global (2016-2021)
7.3.5 Regeneron Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Age Related Macular Degeneration (AMD) Major Product Offerings
7.4.4 Novartis Age Related Macular Degeneration (AMD) Revenue in Global (2016-2021)
7.4.5 Novartis Key News
7.5 Valeant
7.5.1 Valeant Corporate Summary
7.5.2 Valeant Business Overview
7.5.3 Valeant Age Related Macular Degeneration (AMD) Major Product Offerings
7.5.4 Valeant Age Related Macular Degeneration (AMD) Revenue in Global (2016-2021)
7.5.5 Valeant Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Age Related Macular Degeneration (AMD) Major Product Offerings
7.6.4 Pfizer Age Related Macular Degeneration (AMD) Revenue in Global (2016-2021)
7.6.5 Pfizer Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Age Related Macular Degeneration (AMD) Market Opportunities & Trends in Global Market
Table 2. Age Related Macular Degeneration (AMD) Market Drivers in Global Market
Table 3. Age Related Macular Degeneration (AMD) Market Restraints in Global Market
Table 4. Key Players of Age Related Macular Degeneration (AMD) in Global Market
Table 5. Top Age Related Macular Degeneration (AMD) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Age Related Macular Degeneration (AMD) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Age Related Macular Degeneration (AMD) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Age Related Macular Degeneration (AMD) Product Type
Table 9. List of Global Tier 1 Age Related Macular Degeneration (AMD) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Age Related Macular Degeneration (AMD) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type